Focus on Milestone Payments, Part II
Executive Summary
Continuing our analysis of milestone payments that have been made to biotechs by their large pharmaceutical alliance partners in 1996, this month, we look at later-stage milestones; i.e., ones made upon regulatory filings and approvals.